AMRI, Sanofi Win Injunction Blocking Generic Allegra

Law360, New York (June 14, 2010, 6:45 PM EDT) -- Albany Molecular Research Inc. and Sanofi-Aventis US LLC have won their bid for a preliminary injunction preventing Dr. Reddy's Laboratories Inc. from launching a generic version of the allergy drug Allegra in the U.S.

Noting that a preliminary injunction is a “drastic and extraordinary remedy,” Judge Garrett E. Brown Jr. of the U.S. District Court for the District of New Jersey on Monday enjoined Dr. Reddy's from commercial sales of its generic version of Allegra.

The court found that AMRI and Sanofi had successfully established that...
To view the full article, register now.